🇺🇸 FDA
Patent

US 8562993

Methods for treating GI syndrome and graft versus host disease

granted A61KA61K2039/505A61K31/55

Quick answer

US patent 8562993 (Methods for treating GI syndrome and graft versus host disease) held by The Board of Regents of the University of Texas System expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/505, A61K31/55, A61P, A61P1/00